ExoQuick-TC^® ULTRA outperforms other methods, including ultracentrifugation and competitors' kits, by reducing carry-over of albumins by 75% and immunoglobulins by 40%. It also isolates more EVs per normalized input volume and increases the sensitivity of EV biomarker detection by up to 11-fold (CD9) and 8-fold (CD81).